InsiderClue
← All stocks

Incyte

INCY Net buying
CIK 0000879169 #251 in the set updated 17 Sep 2026
Bought (120 mo)
$302.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$244.18M
$53.43M on a plan · $162.91M straight out of an exercise
Sold at will
$27.84M
48 of 301 sales
Net
+$57.82M
+$274.16M against sales at will

By person

39 insiders · 401 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAKER BROS. ADVISORS LP entity
Director
$299.55M (40)
—
+$299.55M
28,486,950
14.05%
$3.58B
−8.5%
Hoppenot Herve
Director
$1.91M (2)
$50.85M (6) scheduled
−$48.93M
326,803
0.1612%
$41.03M
−14.4%
Stein Steven H
CMO & Head of Late-Stage Dev.
—
$28.29M (35) scheduled
−$28.29M
30,916
0.0153%
$3.88M
+56.8%
FRIEDMAN PAUL A
Director
—
$24.72M (6) scheduled
−$24.72M
256,813
0.1267%
$32.25M
−9.1%
SWAIN PAULA J
EVP, Human Resources
—
$23.07M (29) scheduled
−$23.07M
106,482
0.0525%
$13.37M
+264.1%
Flannelly Barry P
EVP & General Manager US
—
$16.16M (34) scheduled
−$16.16M
35,149
0.0173%
$4.41M
+143.6%
Wenqing Yao
EVP, Head of Discovery Chem
—
$13.63M (13) scheduled
−$13.63M
98,575
0.0486%
$12.38M
−28.6%
CAGNONI PABLO J
President, Global Head of R&D
—
$11.30M (7) scheduled
−$11.30M
183,200
0.0904%
$23.00M
+1,016%
Pasquale Maria E
EVP & General Counsel
—
$9.67M (17) scheduled
−$9.67M
69,724
0.0344%
$8.75M
+7,554%
GRYSKA DAVID W
Executive Vice President, CFO
—
$9.18M (8) scheduled
−$9.18M
10,235
0.0050%
$1.29M
−46.2%
Trower Paul
Principal Accounting Officer
—
$8.64M (17) scheduled
−$8.64M
32,268
0.0159%
$4.05M
+151.7%
Iyengar Vijay K
EVP, GMAPPS
—
$8.24M (25) scheduled
−$8.24M
40,540
0.0200%
$5.09M
+401.1%
Morrissey Michael James
EVP, Head of Tech. Operations
—
$7.30M (4) scheduled
−$7.30M
34,065
0.0168%
$4.28M
−20.9%
DIXON WENDY L
Director
—
$6.81M (6) scheduled
−$6.81M
17,768
0.0088%
$2.23M
+112.1%
Mayes Patrick A
EVP & Chief Scientific Officer
—
$6.56M (15) scheduled
−$6.56M
61,441
0.0303%
$7.71M
−8.8%
Huber Reid M
EVP, Chief Scientific Officer
—
$4.28M (7)
−$4.28M
34,571
0.0171%
$4.34M
−49.9%
BROOKE PAUL A
Director
—
$2.96M (1) scheduled
−$2.96M
261,911
0.1292%
$32.89M
+33.4%
Denton Sheila A.
EVP & General Counsel
—
$2.14M (16) scheduled
−$2.14M
26,569
0.0131%
$3.34M
+3,950%
Dickinson Jonathan Elliott
EVP, General Manager, Europe
—
$2.02M (4)
−$2.02M
36,390
0.0180%
$4.57M
+36.1%
Dhanak Dashyant
EVP & Chief Scientific Officer
—
$1.87M (20) scheduled
−$1.87M
58,968
0.0291%
$7.40M
—
Siegel Eric H.
EVP, General Counsel
—
$1.75M (7) scheduled
−$1.75M
21,053
0.0104%
$2.64M
+43.0%
Tray Thomas
Principal Accounting Officer
—
$1.51M (17) scheduled
−$1.51M
21,699
0.0107%
$2.72M
+22.9%
Clancy Paul J
Director
—
$1.42M (1) scheduled
−$1.42M
25,635
0.0126%
$3.22M
—
Issa Mohamed Khairie
EVP, Head of U.S. Commercial
—
$1.31M (2) scheduled
−$1.31M
71,797
0.0354%
$9.01M
—
BIENAIME JEAN JACQUES
Director
$533.44K (7)
$212.89K (3)
+$320.55K
24,424
0.0120%
$3.07M
+3,064%
Heeson Lee
EVP, Head of Incyte Intl
—
$289.02K (1) scheduled
−$289.02K
38,041
0.0188%
$4.78M
—
BAKER JULIAN
Director
—
—
—
767,095
0.3784%
$96.32M
—
Meury William
Chief Executive Officer
—
—
—
183,129
0.0903%
$22.99M
—
Stamoulis Christiana
EVP & Chief Financial Officer
—
—
—
125,759
0.0620%
$15.79M
+6,346%
Upadhyay Suketu
EVP & Chief Financial Officer
—
—
—
26,343
0.0130%
$3.31M
—
HARRIGAN EDMUND
Director
—
—
—
23,019
0.0114%
$2.89M
—
FOUSE JACQUALYN A
Director
—
—
—
20,968
0.0103%
$2.63M
—
Hoffman Richard A.
EVP & General Counsel
—
—
—
16,861
0.0083%
$2.12M
—
Gardner David H
EVP, Chief Strategy Officer
—
—
—
16,824
0.0083%
$2.11M
—
High Katherine A
Director
—
—
—
14,983
0.0074%
$1.88M
—
Trotta Matteo
EVP, GM, Dermatology US
—
—
—
14,882
0.0073%
$1.87M
+3,593%
BRAWLEY OTIS W
Director
—
—
—
12,894
0.0064%
$1.62M
—
Basi Ramitpal K
EVP, Human Resources
—
—
—
10,993
0.0054%
$1.38M
—
Schaffert Susanne
Director
—
—
—
7,389
0.0036%
$927.76K
—

Individual transactions

38
Insider
Date
Role
Action
Shares
Price
Amount
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
175,795
$73.31
$12.89M
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
14,490
$73.31
$1.06M
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
1,017
$71.95
$73.18K
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
84
$71.95
$6.04K
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
25,107
$71.90
$1.81M
BAKER BROS. ADVISORS LP
10 Mar 2022
Director
Buy indirect
2,070
$71.90
$148.83K
BAKER BROS. ADVISORS LP
9 Mar 2022
Director
Buy indirect
65,147
$71.72
$4.67M
BAKER BROS. ADVISORS LP
9 Mar 2022
Director
Buy indirect
5,370
$71.72
$385.14K
BAKER BROS. ADVISORS LP
8 Mar 2022
Director
Buy indirect
92,385
$70.68
$6.53M
BAKER BROS. ADVISORS LP
8 Mar 2022
Director
Buy indirect
7,615
$70.68
$538.19K
BAKER BROS. ADVISORS LP
22 Feb 2022
Director
Buy indirect
92,234
$68.07
$6.28M
BAKER BROS. ADVISORS LP
22 Feb 2022
Director
Buy indirect
7,566
$68.07
$515.03K
BAKER BROS. ADVISORS LP
18 Feb 2022
Director
Buy indirect
22,178
$68.43
$1.52M
BAKER BROS. ADVISORS LP
18 Feb 2022
Director
Buy indirect
1,827
$68.43
$125.02K
BAKER BROS. ADVISORS LP
18 Feb 2022
Director
Buy indirect
100,731
$68.37
$6.89M
BAKER BROS. ADVISORS LP
18 Feb 2022
Director
Buy indirect
8,296
$68.37
$567.17K
BAKER BROS. ADVISORS LP
17 Feb 2022
Director
Buy indirect
285,672
$67.74
$19.35M
BAKER BROS. ADVISORS LP
17 Feb 2022
Director
Buy indirect
7,300
$67.40
$491.98K
BAKER BROS. ADVISORS LP
14 Feb 2022
Director
Buy indirect
182,326
$66.04
$12.04M
BAKER BROS. ADVISORS LP
14 Feb 2022
Director
Buy indirect
320,526
$66.02
$21.16M
BAKER BROS. ADVISORS LP
11 Feb 2022
Director
Buy indirect
10,985
$66.95
$735.43K
BAKER BROS. ADVISORS LP
11 Feb 2022
Director
Buy indirect
265,522
$66.81
$17.74M
BAKER BROS. ADVISORS LP
10 Feb 2022
Director
Buy indirect
772,751
$67.54
$52.19M
BAKER BROS. ADVISORS LP
10 Feb 2022
Director
Buy indirect
6,100
$67.20
$409.90K
BAKER BROS. ADVISORS LP
10 Feb 2022
Director
Buy indirect
40,164
$66.57
$2.67M
BAKER BROS. ADVISORS LP
17 Dec 2021
Director
Buy indirect
193,997
$72.91
$14.14M
BAKER BROS. ADVISORS LP
17 Dec 2021
Director
Buy indirect
881,875
$72.77
$64.18M
BAKER BROS. ADVISORS LP
16 Dec 2021
Director
Buy indirect
29,703
$72.00
$2.14M
BAKER BROS. ADVISORS LP
16 Dec 2021
Director
Buy indirect
139,612
$71.96
$10.05M
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
288,368
$71.91
$20.74M
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
5,382
$71.03
$382.30K
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
9,893
$70.24
$694.84K
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
36,476
$69.63
$2.54M
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
9,352
$68.52
$640.84K
BAKER BROS. ADVISORS LP
15 Dec 2021
Director
Buy indirect
861
$67.90
$58.46K
Hoppenot Herve
23 Feb 2021
Chairman / CEO
Buy
12,925
$77.37
$1.00M
BAKER BROS. ADVISORS LP
28 May 2020
Director
Buy indirect
1
$102.55
$102.55
BAKER BROS. ADVISORS LP
28 May 2020
Director
Buy indirect
1
$102.55
$102.55
Showing 250 of 401 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 919
Amendments (4/A) skipped 3
Filings about a different issuer 4
Unreadable filings 0
Joint filings 64
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 195
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 24,683,547
Sales filed before the plan box existed 47
History held since 26 Sep 2016